BR112017010808A2 - prevenção e tratamento de infecções microbianas - Google Patents

prevenção e tratamento de infecções microbianas

Info

Publication number
BR112017010808A2
BR112017010808A2 BR112017010808A BR112017010808A BR112017010808A2 BR 112017010808 A2 BR112017010808 A2 BR 112017010808A2 BR 112017010808 A BR112017010808 A BR 112017010808A BR 112017010808 A BR112017010808 A BR 112017010808A BR 112017010808 A2 BR112017010808 A2 BR 112017010808A2
Authority
BR
Brazil
Prior art keywords
substance
enzyme
microbial infections
substrate
prevention
Prior art date
Application number
BR112017010808A
Other languages
English (en)
Inventor
Callaghan Annette
Kershaw David
Elder Iain
Staples Ian
Brennan James
Reginald Barrett John
Dryden Matthew
Salib Rami
Patton Thomas
Original Assignee
Matoke Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB201420856A external-priority patent/GB201420856D0/en
Priority claimed from GBGB1508313.2A external-priority patent/GB201508313D0/en
Priority claimed from GBGB1509654.8A external-priority patent/GB201509654D0/en
Priority claimed from GBGB1511576.9A external-priority patent/GB201511576D0/en
Priority claimed from GBGB1513047.9A external-priority patent/GB201513047D0/en
Priority claimed from GBGB1518252.0A external-priority patent/GB201518252D0/en
Priority claimed from GBGB1519483.0A external-priority patent/GB201519483D0/en
Application filed by Matoke Holdings Ltd filed Critical Matoke Holdings Ltd
Publication of BR112017010808A2 publication Critical patent/BR112017010808A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/10—Animals; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)

Abstract

são descritas composições para prevenção e tratamento de infecções microbianas, tais como infecções microbianas que compreendem um biofilme, ou um micróbio que é capaz de formar um biofilme. as composições compreendem uma enzima que é capaz de converter um substrato para liberar peróxido de hidrogênio e uma substância que inclui um substrato para a enzima. a enzima é adicional a qualquer atividade enzimática capaz de converter o substrato para liberar peróxido de hidrogênio que pode estar presente na substância. a substância pode ser uma substância natural não refinada ou uma substância que inclui um substrato purificado para a enzima.
BR112017010808A 2014-11-24 2015-11-24 prevenção e tratamento de infecções microbianas BR112017010808A2 (pt)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB201420856A GB201420856D0 (en) 2014-11-24 2014-11-24 Prevention and treatment of microbial infections
GBGB1508313.2A GB201508313D0 (en) 2015-05-14 2015-05-14 Prevention and treatment of microbial infections
GBGB1509654.8A GB201509654D0 (en) 2015-06-03 2015-06-03 Prevention and treatment of microbial infections
GBGB1511576.9A GB201511576D0 (en) 2015-07-01 2015-07-01 Prevention and treatment of microbial infections
GBGB1513047.9A GB201513047D0 (en) 2015-07-23 2015-07-23 Prevention and treatment of microbial infections
GBGB1518252.0A GB201518252D0 (en) 2015-10-15 2015-10-15 Prevention and treatment of microbial infections
GBGB1519483.0A GB201519483D0 (en) 2015-11-04 2015-11-04 Prevention and treatment of microbial infections
PCT/GB2015/053584 WO2016083798A1 (en) 2014-11-24 2015-11-24 Prevention and treatment of microbial infections

Publications (1)

Publication Number Publication Date
BR112017010808A2 true BR112017010808A2 (pt) 2017-12-26

Family

ID=54782769

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017010808A BR112017010808A2 (pt) 2014-11-24 2015-11-24 prevenção e tratamento de infecções microbianas

Country Status (10)

Country Link
US (1) US20170266240A1 (pt)
EP (2) EP3603654A1 (pt)
JP (3) JP2017535571A (pt)
CN (1) CN107847527A (pt)
AU (1) AU2015352171A1 (pt)
BR (1) BR112017010808A2 (pt)
CA (1) CA2968308A1 (pt)
ES (1) ES2750553T3 (pt)
GB (2) GB2547402B (pt)
WO (1) WO2016083798A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3245871A1 (en) 2014-04-30 2017-11-22 Matoke Holdings Limited Antimicrobial compositions
CA2975197A1 (en) * 2015-02-03 2016-08-11 Matoke Holdings Limited Antimicrobial fibers and compositions
EP3442605A1 (en) * 2016-04-12 2019-02-20 Matoke Holdings Limited Antimicrobial fibers and compositions
WO2017204806A1 (en) 2016-05-26 2017-11-30 Kimberly-Clark Worldwide, Inc. Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface
US20200030347A1 (en) 2016-10-06 2020-01-30 Matoke Holdings Limited Antimicrobial compositions
WO2018065789A1 (en) 2016-10-06 2018-04-12 Matoke Holdings Limited Antimicrobial compositions
WO2019077336A1 (en) * 2017-10-16 2019-04-25 Matoke Holdings Limited DOUBLE DISTRIBUTOR CONTAINING WATER AND ANTIMICROBIAL COMPOSITION
GB201716986D0 (en) * 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
GB201805996D0 (en) 2018-04-11 2018-05-23 Matoke Holdings Ltd Tissue scaffold
EP3946481A2 (en) 2019-03-27 2022-02-09 Matoke Holdings Limited Antimicrobial compositions
MX2021014222A (es) * 2019-05-23 2022-02-21 Arkema Inc Prevencion de enfermedades en abejas meliferas.
WO2021080631A1 (en) * 2019-10-24 2021-04-29 Hydrofera, Llc Wound dressing containing a vacuum pump
GB2589863A (en) * 2019-12-09 2021-06-16 Institute Of Tech Sligo Antimicrobial composition
WO2021186165A1 (en) 2020-03-16 2021-09-23 Matoke Holdings Limited Antimicrobial compositions
RU2759744C1 (ru) * 2020-09-07 2021-11-17 Олег Владимирович Емшанов Способ борьбы с биологическими плёнками
GB202106320D0 (en) 2021-05-04 2021-06-16 Matoke Holdings Ltd Antimicrobial dressing
EP4122477A1 (en) * 2021-07-21 2023-01-25 Mark Edward Fenzl Wound honey with a pump dispenser
GB202210839D0 (en) * 2022-07-25 2022-09-07 Matoke Holdings Ltd Antimicrobial compositions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1987893A (en) 1931-03-26 1935-01-15 Cornell Universlty Honey process and product
JPS58870A (ja) * 1981-06-20 1983-01-06 Hayashibara Biochem Lab Inc 飲食物及びその製造方法
US4617190A (en) * 1984-08-27 1986-10-14 Laclede Professional Products, Inc. Enzymatic powder milk
DK501686A (da) * 1986-10-20 1988-04-21 Otto Melchior Poulsen Enzymholdigt, baktericidt middel samt tandplejemidler og saarbehandlingsmidler, som indeholder det
US5310541A (en) * 1992-08-27 1994-05-10 Montgomery Robert E Antimicrobial rawhide animal chew containing an oxidoreductase and oxidoreductase substrate
BE1017155A3 (nl) * 2006-06-01 2008-03-04 Sanomedical Bvba Wondverzorgingsproduct.
GB0619786D0 (en) * 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system
US20100098645A1 (en) * 2006-10-06 2010-04-22 Institute Of Technology Sligo Formulation and method for the treatment of fungal nail infections
BE1017344A3 (nl) * 2006-10-27 2008-06-03 Cnci Bvba Methode voor het steriliseren van ruwe, onverhitte honing, preparaat voor wondverzorging op basis van honing en een wondverzorging behandelingsproduct.
RU2526906C2 (ru) * 2009-12-04 2014-08-27 Колгейт-Палмолив Компани Неводные однотубные композиции отбеливающего средства чистки зубов, способы их использования и получения
CA2782789A1 (en) * 2009-12-09 2011-06-16 Kci Licensing, Inc. Inhibiting bacterial infection and biofilm formation
EP2611453B1 (en) * 2010-08-30 2021-08-18 Comvita New Zealand Limited Antifungal composition
EP3245871A1 (en) * 2014-04-30 2017-11-22 Matoke Holdings Limited Antimicrobial compositions
FR3020948B1 (fr) * 2014-05-14 2018-04-06 Melipharm Composition antimicrobienne

Also Published As

Publication number Publication date
EP3603654A1 (en) 2020-02-05
GB201709530D0 (en) 2017-08-02
JP2019019141A (ja) 2019-02-07
US20170266240A1 (en) 2017-09-21
AU2015352171A1 (en) 2017-06-08
JP2020158526A (ja) 2020-10-01
GB2554629A (en) 2018-04-04
CN107847527A (zh) 2018-03-27
EP3223833A1 (en) 2017-10-04
GB2554629B8 (en) 2018-10-03
WO2016083798A8 (en) 2016-08-18
GB2547402A (en) 2017-08-16
GB2554629B (en) 2018-09-12
WO2016083798A1 (en) 2016-06-02
JP2017535571A (ja) 2017-11-30
ES2750553T3 (es) 2020-03-26
EP3223833B1 (en) 2019-05-15
GB2547402B (en) 2018-03-28
GB201800813D0 (en) 2018-03-07
CA2968308A1 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
BR112017010808A2 (pt) prevenção e tratamento de infecções microbianas
BR112016025331A2 (pt) composições antimicrobianas
CL2018003213A1 (es) Inhibidores enzimáticos.
GB2550301A (en) Antimicrobial fibers and compositions
CL2015002519A1 (es) Composiciones antimicrobiales y procedimientos de uso relacionados.
CL2016000839A1 (es) Composiciones para modular la expresión de c9orf72.
CO2022000278A2 (es) Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella
BR112015032595A2 (pt) inibidores de ido
PH12015502401A1 (en) Compositions and methods for enhancing microbial stability
BR112017002324A2 (pt) composições de esporo bacteriano para usos industriais
ECSP14017269A (es) Compuestos para tratar la atrofia muscular espinal
ECSP15018618A (es) Inhibidores no nucleósidos de la transcriptasa inversa
CL2018000070A1 (es) Modulares de diaciglicerol aciltransderasa 2 (dgta2)
BR112015026307A2 (pt) heterociclo bicíclicos como inibidores de fgfr
BR112014030812A2 (pt) "compostos tricíclicos substituídos como inibidores de fgfr, seus usos, composição farmacêutica e método para inibir uma enzima fgfr"
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
EA201691461A1 (ru) Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения
CL2017002482A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
SV2017005462A (es) Compuestos de isoxazol de ácido hidroxámico como inhibidores de lpxc
CL2012002624A1 (es) Compuestos derivados del complejo de hierro (iii)-beta-cetoamida; composición que los contiene; medicamento que los comprende; y su uso rara el tratamiento y la profilaxis de síntomas de deficiencia de hierro y las amnemias por deficiencia de hierro y sus síntomas asociados.
CL2018000688A1 (es) Compuestos heterociclicos que contienen bencilamina y composiciones útiles contra infección por micobacterias
GB2548277A (en) Antibiofilm compositions
AR083678A1 (es) Formas cristalinas de la sal de hidrocloruro de (4a-r,9a-s)-1-(1h-benzoimidazol-5-carbonil)-2,3,4,4a,9,9a-hexahidro-1h-indeno[2,1-b]piridina-6-carbonitrilo
BR112016022722A2 (pt) pró-fármacos de inibidores da transcriptase reversa de hiv
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements